Introduction
Toxoplasma
Materials and Methods
A cross sectional observational study was conducted over a period of three years from 1st January 2011 to 31st December 2013 in the Department of Microbiology, Maulana Azad Medical
College and associated Lok Nayak Hospital, New Delhi, India.
This is a centrally located at 1 676 bedded tertiary care hospital with thickly populated catchment areas. Most of the patients fall in the low to middle socio-economic groups.
Informed consent was taken from the patients or the guardians (if the subject was a minor) prior to inclusion into the study. 
Statistical analysis
Data were entered and analyzed using SPSS Age-wise analysis was done using the One-way ANOVA test.
Statistical test result was considered significant whenever P value was < 0.05.
Results

Study population and demographic characteristics
A sample load of 1 181 samples, including 661 samples from HIV positive patients and 520 from HIV negative individuals above 12 years of age, was received over a period of 3 years.
In the HIV positive group, male:female ratio was 
Seroprevalence of Toxoplasma infection
The distribution of Toxoplasma IgG seropositivity among HIV positive and HIV negative serum samples is shown in Table 1 . 
Discussion
Toxoplasmosis, a disease caused by T. gondii has varied presentations depending upon the immune status of the individual and duration of pregnancy at the time of active infection. In the present study, Toxoplasma specific IgG and IgM antibody levels were analyzed using ELISA which is one of the standard methods for detection of anti-Toxoplasma antibodies [4] . IgG seroprevalence of 24.3%, with higher rates in the South India as compared to North India [8] .
In the present study, the prevalence of latent (IgG) Toxoplasma infection in HIV negative individuals was 14.2% (95% CI = 18.4%-24.6%), while in the HIV positive group, it was much higher at 21.3% (95% CI = 17.5%-25.7%). This difference was statistically significant as may be expected because of immunocompromised status of HIV positive patients (P = 0.003).
Unfortunately, very few Indian authors have compared the seroprevalence in HIV infected and HIV non-infected. A study done in Mumbai, Indian compared the two groups and found the seroprevalence in HIV positive to be more than double of that in HIV negative (67.8% vs. 30.9%) [9] . Significantly higher prevalence in HIV positive group has also been reported by international studies from Nigeria [10] , Mali [11] and Ethopia [12] .
However, few studies have denied no significant differences in the latent Toxoplasma seroprevalence between HIV infected and HIV non-infected individuals. In a recent study from Nigeria, Ogoina et al. reported 32.4% in HIV negative healthy adults and 38.7% in HIV-infected adults (P > 0.05) [13] .
Though not statistically significant by ANOVA, age-wise analysis of IgG Toxoplasma seroprevalence in the HIV positive revealed a gradual and regular increase from 9.1% to 30% as the age of the study subjects increased. This can be explained as increasing age increases the possibility of exposure at some point of time in life, and once a person becomes seropositive for IgG against Toxoplasma, he is likely to remain latently infected and in age has also been demonstrated in few other studies [14, 15] .
In case of antenatal women (n = 238), the IgG prevalence was 16.8%. In this group, IgM capture ELISA was also performed as it indicates a recent or active infection, and only women with recent or active infection are at risk of transmitting it to their children.
Thus, early and prompt identification of such cases is essential and should be managed appropriately and with urgency. In the present study, only two women tested positive out of 238 (0.8%).
One woman tested equivocal who was later tested to be negative on repeat testing. Previous study from India has reported a much higher IgG and IgM seroprevalence among pregnant women of 45% and 3.3%, respectively. This may be due to the fact that they used multiple tests like direct agglutination test, IgG and
IgM-ELISA and IgM-immunosorbent agglutination assay [16] .
While another study from India reported 22.4% prevalence of anti-Toxoplasma IgG antibodies among women of child-bearing age [17] .
In conclusion, it can be said that the seroprevalence of latent toxoplasmosis in our region is moderately high, particularly in the HIV infected patients, exposing them to the risk of reactivation. This suggests that serologic testing and cautious follow up of all HIV infected patients is essential to initiate chemoprophylaxis against Toxoplasma when the CD4 + T cell count falls. Likewise, screening of T. gondii infections during antenatal care and preventive education should be considered to prevent and minimize congenital toxoplasmosis.
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